Free Trial

Synopsys, Inc. $SNPS Shares Bought by Callan Family Office LLC

Synopsys logo with Computer and Technology background

Key Points

  • Callan Family Office LLC increased its stake in Synopsys, Inc. by 123.9%, owning 3,510 shares valued at approximately $1.8 million as of the latest reporting period.
  • Analysts have recently revised their ratings on Synopsys, with Morgan Stanley lowering its price target from $715 to $510, and Citigroup downgrading the stock from "neutral" to "underperform."
  • Synopsys reported $2.30 EPS for the latest quarter, significantly missing expectations, and has projected its FY 2025 guidance at 12.760-12.800 EPS.
  • Five stocks we like better than Synopsys.

Callan Family Office LLC increased its holdings in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 123.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,510 shares of the semiconductor company's stock after purchasing an additional 1,942 shares during the quarter. Callan Family Office LLC's holdings in Synopsys were worth $1,800,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in SNPS. Brighton Jones LLC raised its holdings in shares of Synopsys by 5.7% during the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock valued at $447,000 after acquiring an additional 50 shares during the last quarter. Farther Finance Advisors LLC raised its holdings in shares of Synopsys by 9.1% during the first quarter. Farther Finance Advisors LLC now owns 1,899 shares of the semiconductor company's stock valued at $828,000 after acquiring an additional 158 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Synopsys by 26.8% in the first quarter. GAMMA Investing LLC now owns 2,790 shares of the semiconductor company's stock valued at $1,196,000 after purchasing an additional 590 shares during the last quarter. Integrated Advisors Network LLC increased its holdings in shares of Synopsys by 8.0% in the first quarter. Integrated Advisors Network LLC now owns 529 shares of the semiconductor company's stock valued at $227,000 after purchasing an additional 39 shares during the last quarter. Finally, Simon Quick Advisors LLC increased its holdings in shares of Synopsys by 121.5% in the first quarter. Simon Quick Advisors LLC now owns 1,411 shares of the semiconductor company's stock valued at $605,000 after purchasing an additional 774 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.

Analyst Ratings Changes

Several research firms recently commented on SNPS. Morgan Stanley cut their price target on Synopsys from $715.00 to $510.00 and set an "overweight" rating for the company in a report on Thursday, September 11th. Citigroup cut Synopsys from a "neutral" rating to an "underperform" rating in a report on Wednesday, September 10th. JPMorgan Chase & Co. cut their price target on Synopsys from $685.00 to $600.00 and set an "overweight" rating for the company in a report on Wednesday, September 10th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Synopsys in a report on Wednesday. Finally, BNP Paribas initiated coverage on Synopsys in a report on Thursday, October 2nd. They issued an "underperform" rating and a $425.00 price target for the company. Eleven investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, Synopsys has an average rating of "Hold" and a consensus target price of $575.31.

Get Our Latest Stock Analysis on Synopsys

Synopsys Trading Down 9.4%

Shares of Synopsys stock opened at $438.92 on Friday. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The stock has a 50 day moving average of $544.01 and a 200 day moving average of $510.54. The firm has a market capitalization of $81.53 billion, a price-to-earnings ratio of 34.45, a PEG ratio of 4.84 and a beta of 1.10. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The firm had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.77 billion. During the same quarter in the prior year, the business earned $3.43 earnings per share. The company's quarterly revenue was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, research analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Insider Transactions at Synopsys

In other news, Director Robert G. Painter purchased 350 shares of the stock in a transaction dated Thursday, September 11th. The stock was acquired at an average cost of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the transaction, the director directly owned 2,291 shares in the company, valued at approximately $974,683.04. This represents a 18.03% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Sassine Ghazi sold 11,366 shares of the firm's stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total value of $6,694,687.66. Following the transaction, the chief executive officer owned 71,615 shares of the company's stock, valued at approximately $42,181,951.15. This represents a 13.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 30,894 shares of company stock valued at $16,760,783. Corporate insiders own 0.62% of the company's stock.

Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Further Reading

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.